Abstract
Bosnia and Herzegovina (B&H) introduced medicines price regulation based on international reference pricing (IRP) setting maximal allowed wholesaler prices (MWP). Referent countries are Slovenia, Croatia and Serbia. Even this resulted in price decrease, still there are discussions that medicines prices are higher than in neighboring countries. Due to country organization there are differences in retail or reimbursed prices across the country. Prices of medicines are formed by adding distribution and retail margin, and value added tax (VAT). We have conducted analysis on factors affecting prices and suggested possible action to reduce prices.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
